EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER

Our surveillance was performed for 358 patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH. Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 136) received treatment with 75 mg Buserelin-depo 3....

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: S. V. MISHUGIN, A. A. DROBYAZKO, A. A. MORDOVIN, A. A. GRICKEVICH, I. G. RUSAKOV
Format: Artigo
Langue:Russo
Publié: Remedium Group LLC 2017-06-01
Collection:Медицинский совет
Sujets:
prostate cancer
hormone therapy
agonists of luteinizing hormone releasing hormone
buserelin
prostate-specific antigen
testosterone
Accès en ligne:https://www.med-sovet.pro/jour/article/view/1893
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires